HomeCLDX • NASDAQ
Celldex Therapeutics, Inc.
$33.20
After Hours:
$33.27
(0.21%)+0.070
Closed: Sep 27, 6:56:21 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$32.86
Day range
$31.22 - $33.32
Year range
$22.11 - $53.18
Market cap
2.20B USD
Avg Volume
1.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Jun 2024Y/Y change
Revenue
2.50M832.09%
Operating expense
44.93M45.01%
Net income
-35.84M-17.51%
Net profit margin
-1.43K87.39%
Earnings per share
-0.5416.92%
EBITDA
-45.52M-40.28%
Effective tax rate
——
Total assets
Total liabilities
(USD)Jun 2024Y/Y change
Cash and short-term investments
802.32M217.50%
Total assets
845.59M182.51%
Total liabilities
31.93M46.63%
Total equity
813.66M—
Shares outstanding
66.29M—
Price to book
2.68—
Return on assets
-13.51%—
Return on capital
-13.98%—
Net change in cash
(USD)Jun 2024Y/Y change
Net income
-35.84M-17.51%
Cash from operations
-29.33M-7.84%
Cash from investing
-46.72M-4,114.00%
Cash from financing
3.71M2,690.98%
Net change in cash
-72.34M-179.31%
Free cash flow
-17.54M-11.65%
About
Founded
1983
Employees
160
Search
Clear search
Close search
Google apps
Main menu